The War on Sunscreen claims sunscreen causes cancer, and is part of a big pharma conspiracy. Dermatologists disagree.

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Sun Pharmaceutical Industries Ltd. closed 14.55% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

Sun Pharma plans a $100 million investment to commercialize innovative products, including Unloxcyt and Leqselvi, aiming for ...

Sun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, focusing on its specialty business. The company will launch Unloxcyt and ...

Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India's largest listed pharma company, ...

Sun Pharma to invest $100 million in speciality products, targeting growth in innovative treatments for the future.

Sun Pharmaceutical Industries announces a USD 100 million investment to commercialize new speciality products, strengthening ...

Navigating healthcare sector investing amidst market volatility: analysis of funds, performance, and sector trends for ...